ArticleCureus2024
Anti-N-Methyl-D-Aspartate Receptor (Anti-NMDAR) Encephalitis in a Young Pregnant Woman With a 10-Year Follow-Up: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disease of the central nervous system with unknown etiology and multiple triggers. It is clinically characterized by the onset of psychiatric symptoms, seizures, memory disturbance, and cognitive decline. We present a young, newly married woman in the first trimester of pregnancy who presented with purely psychiatric manifestations, fever, and two instances of generalized tonic-clonic seizures. She eventually progressed to develop a decreased level of consciousness and hemodynamic instability. A diagnosis was made of anti-NMDA encephalitis. Her symptoms progressed even after the administration of two intravenous immunoglobulin (IVIG) trials, steroids, and three anti-seizure medications until she experienced a spontaneous abortion. She then gradually returned to her normal baseline condition. This case underscores the importance of suspecting anti-NMDAR encephalitis in pregnant patients with acute onset of psychiatric manifestations. Anti-NMDAR encephalitis can be a difficult, challenging, and exhausting diagnosis for both the patient and treating physicians, particularly in pregnant patients where diagnostic and therapeutic options may be limited due to concerns for fetal safety. However, this case provides evidence that anti-NMDAR encephalitis during pregnancy can have a good prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.